INVO Bioscience is a commercial-stage fertility company focused on expanding the assisted reproductive technology marketplace by making fertility care accessible and inclusive to people around the world.. Co.'s primary product is INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. This treatment solution is an intravaginal culture technique for the incubation of oocytes and sperm during fertilization and early embryo development. The INVO stock yearly return is shown above.
The yearly return on the INVO stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the INVO annual return calculation with any dividends reinvested as applicable (on ex-dates).
|